BofA/Merrill Lynch Downgrades Salix Pharmaceuticals (SLXP) to Neutral

July 3, 2013 7:54 AM EDT
Get Alerts SLXP Hot Sheet
Price: $172.81 --0%

Rating Summary:
    9 Buy, 19 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 11 | Down: 14 | New: 25
Trade SLXP Now!
Join SI Premium – FREE
BofA/Merrill Lynch downgraded Salix Pharmaceuticals (NASDAQ: SLXP) from Buy to Neutral.

For an analyst ratings summary and ratings history on Salix Pharmaceuticals click here. For more ratings news on Salix Pharmaceuticals click here.

Shares of Salix Pharmaceuticals closed at $67.53 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Merrill Lynch, Bank of America

Add Your Comment